76349-0
LaboratoryclonazePAM [Mass/mass] in Meconium by Confirmatory method
Definition
Meconium begins to form in a fetus's gastrointestinal tract by the end of the first trimester of pregnancy. After birth, infants pass meconium stools for the first two to three days of life, at which time they begin to pass breast milk and/or formula stools. Meconium drug testing reflects maternal drug use during at least the last three months of pregnancy, and possibly during the last four to five months.
LOINC 6-Axis Classification
Component
clonazePAM
Property
MCnt
Time Aspect
Pt
System
Meconium
Scale Type
Qn
Method Type
Confirm
Details
Class
DRUG/TOX
Order/Observation
Both
Short Name
clonazePAM Mec Cfm-mCnt
Display Name
clonazePAM Confirm (Mec) [Mass/Mass]
Related Names
Frequently Asked Questions
What is LOINC code 76349-0?
LOINC code 76349-0 identifies "clonazePAM [Mass/mass] in Meconium by Confirmatory method". Meconium begins to form in a fetus's gastrointestinal tract by the end of the first trimester of pregnancy. After birth, infants pass meconium stools for the first two to three days of life, at which time they begin to pass breast milk and/or formula stools. Meconium drug testing reflects maternal drug use during at least the last three months of pregnancy, and possibly during the last four to five months.
What does 76349-0 measure?
This code measures clonazePAM in Meconium. It belongs to the DRUG/TOX class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.